|
|
| (29 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| {{DrugProjectFormSinglePage
| | #REDIRECT [[Enalapril]] |
| |authorTag={{AZ}}, {{AM}}
| |
| |genericName=Epaned, Vasotec
| |
| |aOrAn=an
| |
| |drugClass=Angiontensin converting enzyme inhibitor
| |
| |indication=[[hypertension]], [[heart failure]], left ventricular dysfunction after [[myocardial infarction]], [[diabetic nephropathy]]
| |
| |hasBlackBoxWarning=Yes
| |
| |adverseReactions=[[Hyperkalemia]] (1% to 3.8% ), [[dizziness]] (4.3% to 7.9% ), increase in serum blood urea nitrogen (0.2% to 11% ), increase in serum [[creatinine]] (0.2% to 11% ), [[fatigue]] (3% )
| |
| |blackBoxWarningTitle=USE IN PREGNANCY
| |
| |blackBoxWarningBody=<i><span style="color:#FF0000;">Condition Name:</span></i> When used in pregnancy during the second and third trimesters, ACE inhibitors can cause injury and even death to the developing fetus. When pregnancy is detected, enalapril maleate should be discontinued as soon as possible. See WARNINGS, Fetal / Neonatal Morbidity and Mortality.
| |
| |fdaLIADAdult=<h4>Condition 1</h5>
| |
| | |
| * Dosing Information
| |
| | |
| :: (Dosage)
| |
| |useInPed=* The effects of enalapril maleate as an Antihypertensive have been established in hypertensive pediatric patients age 1 month to 16 years. Use of enalapril maleate in these age groups is supported by evidence from adequate and well-controlled studies of enalapril maleate in pediatric and adult patients as well as by published literature in pediatric patients.
| |
| | |
| * For pediatric hypertensive patients, the usual recommended starting dose is 0.08 mg/kg (up to 5 mg) once daily. Dosage should be adjusted according to blood pressure response. Doses above 0.58 mg/kg (or in excess of 40 mg) have not been studied in pediatric patients.
| |
| | |
| * Enalapril maleate is not recommended in neonates and in pediatric patients with glomerular filtration rate less than 30 mL/min/1.73 m2, as no data are available.
| |
| |useInGeri=FDA Package Insert for {{PAGENAME}} contains no information regarding ''Geriatrics''.
| |
| |useInGender=FDA Package Insert for {{PAGENAME}} contains no information regarding ''Gender''.
| |
| |useInRace=FDA Package Insert for {{PAGENAME}} contains no information regarding ''Race''.
| |
| }}
| |